Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112853
Status:
COMPLETED
Last Update Posted:
2013-01-09
First Post:
2005-06-02
Brief Title:
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Acute Megakaryoblastic Leukemia M7 |
| Adult Acute Minimally Differentiated Myeloid Leukemia M0 |
| Adult Acute Monoblastic Leukemia M5a |
| Adult Acute Monocytic Leukemia M5b |
| Adult Acute Myeloblastic Leukemia With Maturation M2 |
| Adult Acute Myeloblastic Leukemia Without Maturation M1 |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Adult Acute Myelomonocytic Leukemia M4 |
| Adult Erythroleukemia M6a |
| Adult Pure Erythroid Leukemia M6b |
| Secondary Acute Myeloid Leukemia |
| Untreated Adult Acute Myeloid Leukemia |
Keywords: